Lista de obras -

A novel method for rapid molecular subgrouping of medulloblastoma.

artículo científico publicado en 2018

A three-gene expression signature model for risk stratification of patients with neuroblastoma

artículo científico publicado en 2012

Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature

artículo científico publicado en 2010

BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma

scientific article published in 2022

Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

artículo científico publicado en 2016

Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma

scientific article published on 22 September 2020

Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

artículo científico publicado en 2015

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

artículo científico publicado en 2014

Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma

artículo científico publicado en 2007

Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells

artículo científico publicado en 2009

Craniospinal irradiation as a salvage treatment for metastatic relapsed DIPG

scientific article published on 16 October 2020

Cytogenetic prognostication within medulloblastoma subgroups

artículo científico publicado en 2014

DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis

artículo científico publicado en 2012

DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights

artículo científico publicado en 2015

DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights

artículo científico publicado en 2015

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.

artículo científico publicado en 2018

Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status

artículo científico publicado en 2008

EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

artículo científico publicado en 2017

Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma

artículo científico publicado en 2010

Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility

artículo científico publicado en 2021

Genetic variants in the promoter region of the calcium-sensing receptor gene are associated with its down-regulation in neuroblastic tumors

artículo científico publicado en 2016

HG-110SINGLE-CELL TRANSCRIPTOME ANALYSIS IN PEDIATRIC HEMISPHERIC AND MIDLINE HIGH-GRADE GLIOMAS.

artículo científico publicado en 2016

Identification of a putative transcriptome signature common to neuroblastoma and neural crest cells.

artículo científico publicado en 2013

Identification of tumoral glial precursor cells in neuroblastoma

artículo científico publicado en 2011

Locoregional MYCN-amplified neuroblastoma

artículo científico publicado en 2012

Old drugs still work! Oral etoposide in a relapsed medulloblastoma

artículo científico publicado en 2019

Parathyroid hormone-like hormone plays a dual role in neuroblastoma depending on PTH1R expression

artículo científico publicado en 2019

Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma

artículo científico publicado en 2013

Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.

artículo científico publicado en 2016

RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein

artículo científico publicado en 2016

RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

artículo científico publicado en 2020

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

artículo científico publicado en 2009

Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8.

artículo científico publicado en 2017

The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors

artículo científico publicado en 2009

The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.

artículo científico publicado en 2012

The genomic landscape of pediatric Ewing sarcoma

artículo científico publicado en 2014

The molecular landscape of glioma in patients with Neurofibromatosis 1

artículo científico publicado en 2018

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

artículo científico publicado en 2019

Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration

artículo científico publicado en 2020

Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution

scientific article published on 01 June 2020

Use of siRNAs and Antisense Oligonucleotides Against Survivin RNA to Inhibit Steps Leading to Tumor Angiogenesis

artículo científico publicado en 2004

XAF1 as a modifier of p53 function and cancer susceptibility

scientific article published on 24 June 2020

Lista de obras de

A novel method for rapid molecular subgrouping of medulloblastoma.

A three-gene expression signature model for risk stratification of patients with neuroblastoma

Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature

BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma

Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma

Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma

Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells

Craniospinal irradiation as a salvage treatment for metastatic relapsed DIPG

Cytogenetic prognostication within medulloblastoma subgroups

DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis

DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights

DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.

Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status

EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma

Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility

Genetic variants in the promoter region of the calcium-sensing receptor gene are associated with its down-regulation in neuroblastic tumors

HG-110SINGLE-CELL TRANSCRIPTOME ANALYSIS IN PEDIATRIC HEMISPHERIC AND MIDLINE HIGH-GRADE GLIOMAS.

Identification of a putative transcriptome signature common to neuroblastoma and neural crest cells.

Identification of tumoral glial precursor cells in neuroblastoma

Locoregional MYCN-amplified neuroblastoma

Old drugs still work! Oral etoposide in a relapsed medulloblastoma

Parathyroid hormone-like hormone plays a dual role in neuroblastoma depending on PTH1R expression

Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma

Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.

RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein

RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8.

The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors

The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.

The genomic landscape of pediatric Ewing sarcoma

The molecular landscape of glioma in patients with Neurofibromatosis 1

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration

Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution

Use of siRNAs and Antisense Oligonucleotides Against Survivin RNA to Inhibit Steps Leading to Tumor Angiogenesis

XAF1 as a modifier of p53 function and cancer susceptibility